Amendment No. 1 to Right of First Refusal AgreementRight of First Refusal Agreement • September 11th, 2020 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledSeptember 11th, 2020 Company Industry JurisdictionThis Amendment No. 1 to Right of First Refusal Agreement (“Amendment”) entered into between PharmaCyte Biotech, Inc. (“PharmaCyte”) and Silver Rock Associates, Inc. (“Silver Rock”) dated July 15, 2020.
RIGHT OF FIRST REFUSAL AGREEMENTRight of First Refusal Agreement • September 11th, 2020 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledSeptember 11th, 2020 Company Industry JurisdictionThis Right of First Refusal Agreement (“Agreement”) is entered into between PharmaCyte Biotech, Inc. (“PharmaCyte”) and Silver Associates, Inc. (“Silver Rock”) as of May 4, 2020 based upon the following: